AMP Capital Investors’s Medpace MEDP Stock Holding History

AMP Capital Investors’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,100	Closed	-$345K	–	1290
2020 Q3	$345K	Hold	3,100	–	–	﹤0.01%	1016
2020 Q2	$280K	Hold	3,100	–	–	﹤0.01%	1043
2020 Q1	$233K	Hold	3,100	–	–	﹤0.01%	1026
2019 Q4	$258K	Hold	3,100	–	–	﹤0.01%	1095
2019 Q3	$258K	Buy	+3,100	New	+$234K	﹤0.01%	1094
2018 Q3	–	Sell	-5,800	Closed	-$249K	–	1171
2018 Q2	$249K	Buy	+5,800	New	+$234K	﹤0.01%	1103

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

AMP Capital Investors's MEDP Position: Q4 2020 in Review

AMP Capital Investors sold out of Medpace (MEDP) in Q4 2020, closing a stake of 3,100 shares — an estimated $345K sold.

AMP Capital Investors first reported a position in MEDP in Q2 2018 and held it in 6 quarters. The position peaked at $345K in Q3 2020. 316 funds tracked by Wall St. Rank hold MEDP as of Q4 2020.

AMP Capital Investors reported no remaining Medpace position as of Q4 2020 after selling out during the quarter.
AMP Capital Investors sold 3,100 Medpace shares in Q4 2020, an estimated $345K.
AMP Capital Investors first reported a position in Medpace in Q2 2018 and held it in 6 quarters.
AMP Capital Investors's Medpace position peaked at $345K in Q3 2020.
316 funds tracked by Wall St. Rank held Medpace as of Q4 2020.

Based on AMP Capital Investors's 13F filing for Q4 2020, filed 12 Feb 2021.